Meghmani Organics Share Price
Sector: Chemical Manufacturing
74.08 -1.41 (-1.87%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
73.61
Today’s High
76.00
52 Week Low
57.00
52 Week High
116.00
73.94 -1.54 (-2.04%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
73.12
Today’s High
76.00
52 Week Low
56.11
52 Week High
115.95
Key Metrics
- Market Cap (In Cr) 1883.96
- Beta 0.76
- Div. Yield (%) 0
- P/B 1.23
- TTM P/E -
- Sector P/E 17.95
- Open Price 75.49
- Prev Close 75.49
Meghmani Organics Analysis
Price Analysis
-
1 Week15.91%
-
3 Months-8.48%
-
6 Month-32.51%
-
YTD-3.92%
-
1 Year-14.22%
Risk Meter
- 46% Low risk
- 46% Moderate risk
- 46% Balanced Risk
- 46% High risk
- 46% Extreme risk
Meghmani Organics News
Stocks to buy under ₹100: Experts recommend six shares to buy today — 18 Feb
2 min read . 18 Feb 2025Stocks to buy under ₹100: Experts recommend six intraday stocks for today
2 min read . 10 Jan 2025Small-cap stocks under ₹100: Experts recommend six shares to buy on Monday
3 min read . 28 Dec 2024Meghmani Organics Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1566.28
- Selling/ General/ Admin Expenses Total
- 262.19
- Depreciation/ Amortization
- 92.22
- Other Operating Expenses Total
- 66.11
- Total Operating Expense
- 1676.88
- Operating Income
- -110.6
- Net Income Before Taxes
- -121.18
- Net Income
- -106.03
- Diluted Normalized EPS
- -4.15
- Period
- 2024
- Total Assets
- 3040.14
- Total Liabilities
- 1512.45
- Total Equity
- 1527.69
- Tangible Book Valueper Share Common Eq
- 59.52
- Period
- 2024
- Cashfrom Operating Activities
- 249.68
- Cashfrom Investing Activities
- -178.38
- Cashfrom Financing Activities
- -85.48
- Net Changein Cash
- -14.18
- Period
- 2023
- Total Revenue
- 2552.62
- Selling/ General/ Admin Expenses Total
- 512.76
- Depreciation/ Amortization
- 77.06
- Other Operating Expenses Total
- 74.24
- Total Operating Expense
- 2268.41
- Operating Income
- 284.22
- Net Income Before Taxes
- 313.09
- Net Income
- 237.71
- Diluted Normalized EPS
- 8.8
- Period
- 2023
- Total Assets
- 3198.44
- Total Liabilities
- 1529.22
- Total Equity
- 1669.23
- Tangible Book Valueper Share Common Eq
- 65.17
- Period
- 2023
- Cashfrom Operating Activities
- 204.47
- Cashfrom Investing Activities
- -417.64
- Cashfrom Financing Activities
- 233.73
- Net Changein Cash
- 20.57
- Period
- 2022
- Total Revenue
- 2498.46
- Selling/ General/ Admin Expenses Total
- 309.16
- Depreciation/ Amortization
- 62.65
- Other Operating Expenses Total
- 63.41
- Total Operating Expense
- 2155.03
- Operating Income
- 343.43
- Net Income Before Taxes
- 408.8
- Net Income
- 304.42
- Diluted Normalized EPS
- 11.81
- Period
- 2022
- Total Assets
- 2797.61
- Total Liabilities
- 1331.39
- Total Equity
- 1466.22
- Tangible Book Valueper Share Common Eq
- 57.22
- Period
- 2022
- Cashfrom Operating Activities
- 65
- Cashfrom Investing Activities
- -132.94
- Cashfrom Financing Activities
- 57.72
- Net Changein Cash
- -10.23
- Period
- 2021
- Total Revenue
- 1636.66
- Selling/ General/ Admin Expenses Total
- 243.99
- Depreciation/ Amortization
- 50.68
- Other Operating Expenses Total
- 47.53
- Total Operating Expense
- 1395.99
- Operating Income
- 240.66
- Net Income Before Taxes
- 251.8
- Net Income
- 186.48
- Diluted Normalized EPS
- 7.17
- Period
- 2021
- Total Assets
- 1974.15
- Total Liabilities
- 801.12
- Total Equity
- 1173.03
- Tangible Book Valueper Share Common Eq
- 45.69
- Period
- 2021
- Cashfrom Operating Activities
- 333.39
- Cashfrom Investing Activities
- -306.93
- Cashfrom Financing Activities
- -14.24
- Net Changein Cash
- 12.22
- Period
- 2020
- Total Revenue
- 2191.18
- Selling/ General/ Admin Expenses Total
- 282.4
- Depreciation/ Amortization
- 88.59
- Other Operating Expenses Total
- 55.18
- Total Operating Expense
- 1843.67
- Operating Income
- 347.51
- Net Income Before Taxes
- 359.04
- Net Income
- 240.15
- Diluted Normalized EPS
- 9.49
- Period
- 2020
- Total Assets
- 2736.92
- Total Liabilities
- 1527.86
- Total Equity
- 1209.06
- Tangible Book Valueper Share Common Eq
- 46.58
- Period
- 2020
- Cashfrom Operating Activities
- 404.28
- Cashfrom Investing Activities
- -480.8
- Cashfrom Financing Activities
- -48.18
- Net Changein Cash
- -124.71
- Period
- 2019
- Total Revenue
- 2087.96
- Selling/ General/ Admin Expenses Total
- 296.42
- Depreciation/ Amortization
- 97.26
- Other Operating Expenses Total
- 49.28
- Total Operating Expense
- 1633.75
- Operating Income
- 454.21
- Net Income Before Taxes
- 408.56
- Net Income
- 251.27
- Diluted Normalized EPS
- 10.44
- Period
- 2019
- Total Assets
- 2376.76
- Total Liabilities
- 1373.16
- Total Equity
- 1003.6
- Tangible Book Valueper Share Common Eq
- 38.82
- Period
- 2019
- Cashfrom Operating Activities
- 375.23
- Cashfrom Investing Activities
- -291.3
- Cashfrom Financing Activities
- 45.11
- Net Changein Cash
- 129.04
- Period
- 2018
- Total Revenue
- 1843.17
- Selling/ General/ Admin Expenses Total
- 224.47
- Depreciation/ Amortization
- 94.77
- Other Operating Expenses Total
- 65.31
- Total Operating Expense
- 1503.1
- Operating Income
- 340.07
- Net Income Before Taxes
- 325.71
- Net Income
- 171.32
- Diluted Normalized EPS
- 6.81
- Period
- 2018
- Total Assets
- 1818.41
- Total Liabilities
- 947.88
- Total Equity
- 870.54
- Tangible Book Valueper Share Common Eq
- 32.49
- Period
- 2018
- Cashfrom Operating Activities
- 404.89
- Cashfrom Investing Activities
- -274.5
- Cashfrom Financing Activities
- -128.23
- Net Changein Cash
- 2.16
- Period
- 2024-12-31
- Total Revenue
- 568.51
- Selling/ General/ Admin Expenses Total
- 28.2
- Depreciation/ Amortization
- 29.67
- Other Operating Expenses Total
- 154.8
- Total Operating Expense
- 557.35
- Operating Income
- 11.16
- Net Income Before Taxes
- 7.41
- Net Income
- -4.39
- Diluted Normalized EPS
- -0.17
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 543.89
- Selling/ General/ Admin Expenses Total
- 28.65
- Depreciation/ Amortization
- 25.49
- Other Operating Expenses Total
- 139.96
- Total Operating Expense
- 538.81
- Operating Income
- 5.08
- Net Income Before Taxes
- -9.17
- Net Income
- -9.27
- Diluted Normalized EPS
- -0.36
- Period
- 2024-09-30
- Total Assets
- 3193.84
- Total Liabilities
- 1694.55
- Total Equity
- 1499.29
- Tangible Book Valueper Share Common Eq
- 58.35
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 84.73
- Cashfrom Investing Activities
- -3.7
- Cashfrom Financing Activities
- -74.75
- Net Changein Cash
- 6.28
- Period
- 2024-06-30
- Total Revenue
- 413.88
- Selling/ General/ Admin Expenses Total
- 27.82
- Depreciation/ Amortization
- 23.48
- Other Operating Expenses Total
- 117.44
- Total Operating Expense
- 431.5
- Operating Income
- -17.62
- Net Income Before Taxes
- -19.32
- Net Income
- -16.76
- Diluted Normalized EPS
- -0.66
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 410.03
- Selling/ General/ Admin Expenses Total
- 28.64
- Depreciation/ Amortization
- 22.8
- Other Operating Expenses Total
- 129.44
- Total Operating Expense
- 430.81
- Operating Income
- -20.77
- Net Income Before Taxes
- -14.32
- Net Income
- -17.96
- Diluted Normalized EPS
- -0.71
- Period
- 2024-03-31
- Total Assets
- 3040.14
- Total Liabilities
- 1512.45
- Total Equity
- 1527.69
- Tangible Book Valueper Share Common Eq
- 59.52
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 249.68
- Cashfrom Investing Activities
- -178.38
- Cashfrom Financing Activities
- -85.48
- Net Changein Cash
- -14.18
- Period
- 2023-12-31
- Total Revenue
- 351.75
- Selling/ General/ Admin Expenses Total
- 27.78
- Depreciation/ Amortization
- 23.13
- Other Operating Expenses Total
- 100.88
- Total Operating Expense
- 382.68
- Operating Income
- -30.93
- Net Income Before Taxes
- -47.94
- Net Income
- -38.23
- Diluted Normalized EPS
- -1.5
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 378.72
- Selling/ General/ Admin Expenses Total
- 29.96
- Depreciation/ Amortization
- 22.71
- Other Operating Expenses Total
- 108.15
- Total Operating Expense
- 393.84
- Operating Income
- -15.12
- Net Income Before Taxes
- -15.79
- Net Income
- -15.34
- Diluted Normalized EPS
- -0.6
- Period
- 2023-09-30
- Total Assets
- 2937.2
- Total Liabilities
- 1352.95
- Total Equity
- 1584.25
- Tangible Book Valueper Share Common Eq
- 61.79
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 145.91
- Cashfrom Investing Activities
- -138.36
- Cashfrom Financing Activities
- -23.24
- Net Changein Cash
- -15.7
- Period
- 2023-06-30
- Total Revenue
- 425.78
- Selling/ General/ Admin Expenses Total
- 29.57
- Depreciation/ Amortization
- 23.59
- Other Operating Expenses Total
- 109.05
- Total Operating Expense
- 471.45
- Operating Income
- -45.67
- Net Income Before Taxes
- -43.14
- Net Income
- -34.5
- Diluted Normalized EPS
- -1.36
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 574.08
- Selling/ General/ Admin Expenses Total
- 31.65
- Depreciation/ Amortization
- 22.58
- Other Operating Expenses Total
- 129.19
- Total Operating Expense
- 499.95
- Operating Income
- 74.13
- Net Income Before Taxes
- 66.98
- Net Income
- 54.15
- Diluted Normalized EPS
- 1.53
- Period
- 2023-03-31
- Total Assets
- 3198.44
- Total Liabilities
- 1529.22
- Total Equity
- 1669.23
- Tangible Book Valueper Share Common Eq
- 65.17
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 204.47
- Cashfrom Investing Activities
- -417.64
- Cashfrom Financing Activities
- 233.73
- Net Changein Cash
- 20.57
- Period
- 2022-12-31
- Total Revenue
- 549.43
- Selling/ General/ Admin Expenses Total
- 27.7
- Depreciation/ Amortization
- 18.09
- Other Operating Expenses Total
- 121.15
- Total Operating Expense
- 514.63
- Operating Income
- 34.8
- Net Income Before Taxes
- 15.44
- Net Income
- 8.35
- Diluted Normalized EPS
- 0.33
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Meghmani Organics Technical
Moving Average
SMA
- 5 Day68.68
- 10 Day67.26
- 20 Day65.91
- 50 Day69.2
- 100 Day77.15
- 300 Day86.32
Meghmani Organics Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Insecticides India
- 688
- 12.75
- 1.89
- 1084.65
- 475.5
- 2001.93
- Iol Chemicals And Pharmaceu
- 66.49
- 2.29
- 3.57
- 107.41
- 57.51
- 1951.66
- Meghmani Organics
- 74.08
- -1.41
- -1.87
- 116
- 57
- 1883.96
- Southern Petrochemicals Indust
- 85.84
- 1.04
- 1.23
- 96.69
- 64.35
- 1748.05
- Tatva Chintan Pharma Chem
- 718.2
- -4.45
- -0.62
- 1280
- 610
- 1680.02
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Insecticides India
- 20.23
- 2.02
- 10.86
- 5.63
- Iol Chemicals And Pharmaceu
- 14.57
- 1.22
- 20.73
- 12
- Meghmani Organics
- -
- 1.23
- 12.72
- 8.73
- Southern Petrochemicals Indust
- 11.81
- 1.63
- 21.43
- 7.01
- Tatva Chintan Pharma Chem
- 54.26
- 2.29
- 15.58
- 14.43
Meghmani Organics Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 08-Feb-25
- Quarterly Results
- 26-Oct-24
- Quarterly Results
- 27-Jul-24
- Quarterly Results
- 11-May-24
- Audited Results
- 30-Jan-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 29-Apr-23
- Audited Results & Final Dividend
- 21-Jan-23
- Quarterly Results
- 21-Oct-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 09-Jul-24
- 18-Jun-24
- AGM
- 12-Dec-23
- 13-Nov-23
- POM
- 23-Sept-23
- 22-Aug-23
- POM
- 27-Jun-23
- 29-Apr-23
- AGM
- 27-Jun-22
- 02-May-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 02-May-23
- 20-Jun-23
- 20-Jun-23
- 1.4
- 02-May-22
- 20-Jun-22
- 17-Jun-22
- 1.4
- 13-Sept-21
- -
- 15-Sept-21
- 1.4


